Atavistik Bio Raises $60m For Metabolic Disease, Cancer Drug Discovery

Acting CEO Comes From Peloton; President/CSO From Blueprint, Agios

 
• By Mandy Jackson
Innovation and creative idea concept
Atavistik is The Column Group's latest start-up built around a novel drug discovery platform • Source: Alamy

More from Financing

More from Business